July 26, 2021
The CDC quietly announced last week that it was withdrawing its request to the FDA for Emergency Use Authorization (EUA) of the 2019-Novel Coronavirus PCR Diagnostic Panel for detection of SARS-CoV-2 (the name for the COVID-19 virus). It now recommends laboratories adopt a method that can detect and differentiate SARS-CoV-2 from influenza viruses. The US has used the PCR test to report more than 34.4-million cases of the COVID-19 since the pandemic began and more than 610,000 deaths. Covid cases based on this test soared nationwide while, at the same time, hospitalizations and deaths from the Flu dropped to near zero. There were only 646 deaths relating to the flu among adults reported in 2020, whereas in 2019 the CDC estimated that between 24,000 and 62,000 people died from influenza-related illnesses, according to Fox News. The CDC now recommends that laboratories start transitioning to other types of COVID-19 diagnostic tests that can test for both COVID-19 and the flu. -GEG
Read More HERE
